Speakers

Bryan Kobel

CEO • TC Biopharm

Bryan Kobel serves as TC BioPharm’s Chief Executive Officer, having joined TC BioPharm, with a view to assuming that role, in June 2021. Prior to joining TC BioPharm he served as Managing Director at EF Hutton from October 2020 as the head of healthcare investment banking. From June 2018 to October 2020, Mr Kobel was Managing Director and head of healthcare/capital markets at the Alberleen Group where he led deal origination and structuring, as well as leading the sales efforts for transactions across the Healthcare and Technology sectors. From April 2017 to June 2018, he was Head of Capital Markets at R.F. Lafferty & Co. From March 2012 to April 2017, Mr Kobel was Managing Director, Capital Markets at Laidlaw & Company. Mr. Kobel holds a BA degree from Franklin & Marshall College and held the FINRA licenses Series 7, 63, 82, 79 and 24.

Also speaking

Melanie Calvert

Professor of Outcomes Methodology • University of Birmingham CPROR

Elsa Abranches

Senior Director – Head of Cell Therapy Bioprocess Development and Manufacturing • AstraZeneca

Shree Patel

EVP Patient Supply Operations • Achilles Therapeutics

Event Info

Image

2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.
Image

Pub & Pints RSVP

Let us know you’re planning on attending.